Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 1
2006 1
2010 1
2013 2
2014 1
2015 6
2016 2
2017 5
2018 6
2019 4
2020 4
2021 5
2022 9
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
S100B in cardiac surgery brain monitoring: friend or foe?
Lapergola G, Graziosi A, D'Adamo E, Brindisino P, Ferrari M, Romanelli A, Strozzi M, Libener R, Gavilanes DAW, Maconi A, Satriano A, Varrica A, Gazzolo D. Lapergola G, et al. Among authors: libener r. Clin Chem Lab Med. 2022 Jan 11;60(3):317-331. doi: 10.1515/cclm-2021-1012. Print 2022 Feb 23. Clin Chem Lab Med. 2022. PMID: 35001583 Free article. Review.
Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos.
Di Mauro G, Frontini F, Torreggiani E, Iaquinta MR, Caselli A, Mazziotta C, Esposito V, Mazzoni E, Libener R, Grosso F, Maconi A, Martini F, Bononi I, Tognon M. Di Mauro G, et al. Among authors: libener r. Sci Rep. 2023 Apr 20;13(1):6501. doi: 10.1038/s41598-023-33116-z. Sci Rep. 2023. PMID: 37081052 Free PMC article.
Circulating microRNA-197-3p as a potential biomarker for asbestos exposure.
Frontini F, Bononi I, Torreggiani E, Di Mauro G, Mazzoni E, Stendardo M, Boschetto P, Libener R, Guaschino R, Grosso F, Guerra G, Martini F, Tognon M. Frontini F, et al. Among authors: libener r. Sci Rep. 2021 Dec 14;11(1):23955. doi: 10.1038/s41598-021-03189-9. Sci Rep. 2021. PMID: 34907223 Free PMC article. Clinical Trial.
Diagnostics of BAP1-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience.
Sculco M, La Vecchia M, Aspesi A, Clavenna MG, Salvo M, Borgonovi G, Pittaro A, Witel G, Napoli F, Listì A, Grosso F, Libener R, Maconi A, Rena O, Boldorini R, Giachino D, Bironzo P, Maffè A, Alì G, Elefanti L, Menin C, Righi L, Tampieri C, Scagliotti GV, Dianzani C, Ferrante D, Migliore E, Magnani C, Mirabelli D, Matullo G, Dianzani I. Sculco M, et al. Among authors: libener r. Diagnostics (Basel). 2022 Jul 13;12(7):1710. doi: 10.3390/diagnostics12071710. Diagnostics (Basel). 2022. PMID: 35885614 Free PMC article.
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment.
Sculco M, La Vecchia M, Aspesi A, Pinton G, Clavenna MG, Casalone E, Allione A, Grosso F, Libener R, Muzio A, Rena O, Baietto G, Parini S, Boldorini R, Giachino D, Papotti M, Scagliotti GV, Migliore E, Mirabelli D, Moro L, Magnani C, Ferrante D, Matullo G, Dianzani I. Sculco M, et al. Among authors: libener r. Eur J Cancer. 2022 Mar;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 13. Eur J Cancer. 2022. PMID: 35032816 Free article.
Asbestos fibre burden in gallbladder: A case study.
Croce A, Capella S, Belluso E, Grosso F, Mariani N, Libener R, Rinaudo C. Croce A, et al. Among authors: libener r. Micron. 2018 Feb;105:98-104. doi: 10.1016/j.micron.2017.12.001. Epub 2017 Dec 8. Micron. 2018. PMID: 29248759
New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment.
Cugliari G, Allione A, Russo A, Catalano C, Casalone E, Guarrera S, Grosso F, Ferrante D, Sculco M, La Vecchia M, Pirazzini C, Libener R, Mirabelli D, Magnani C, Dianzani I, Matullo G. Cugliari G, et al. Among authors: libener r. Cancers (Basel). 2021 May 27;13(11):2636. doi: 10.3390/cancers13112636. Cancers (Basel). 2021. PMID: 34071989 Free PMC article.
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.
Salaroglio IC, Belisario DC, Bironzo P, Ananthanarayanan P, Ricci L, Digiovanni S, Fontana S, Napoli F, Sandri A, Facolmatà C, Libener R, Comunanza V, Grosso F, Gazzano E, Leo F, Taulli R, Bussolino F, Righi L, Papotti MG, Novello S, Scagliotti GV, Riganti C, Kopecka J. Salaroglio IC, et al. Among authors: libener r. J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7. J Exp Clin Cancer Res. 2022. PMID: 35197103 Free PMC article.
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma.
Anobile DP, Bironzo P, Picca F, Lingua MF, Morena D, Righi L, Napoli F, Papotti MG, Pittaro A, Di Nicolantonio F, Gigliotti C, Bussolino F, Comunanza V, Guerrera F, Sandri A, Leo F, Libener R, Aviles P, Novello S, Taulli R, Scagliotti GV, Riganti C. Anobile DP, et al. Among authors: libener r. Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332. Cancers (Basel). 2021. PMID: 34066159 Free PMC article.
50 results